By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – 23andMe today announced it is using the services of Informed Medical Decisions to provide genetic counseling to new and existing customers of its Personal Genome Service.
Terms of the deal were not disclosed.
...and receive Daily News bulletins.
Already have an account?Login Now.
The US Food and Drug Administration has approved Alnylam's RNAi-based therapy Onpattro, according to Stat News.
Harvard Medical School's Seth Cassel and Cigall Kadoch argue in a Baltimore Sun op-ed that the recent TAILORx trial shows the potential of genomic-based medicine.
Researchers in the UK are working on using gene drives to control malaria-carrying mosquitoes, the Telegraph reports.
In PLOS this week: genetic architecture mediating gene expression, metabolomic patterns in multiple myeloma, and more.
This webinar will provide an overview of recent advances in single-cell RNA sequencing from the perspectives of three research organizations.
This webinar offers a look at how an advanced genetics laboratory implemented and validated a commercial bioinformatics system to help scale its operations.
In this webinar, Kevin Balbi, head of bioinformatics at Sarah Cannon Molecular Diagnostics, will discuss the validation of targeted sequencing panels on the Ion Torrent platform using Horizon Discovery’s Tru-Q controls.